Recombinant Human GAGE12B Protein，GST

GAGE12B is a member of the GAGE family of genes, which are known for their expression in various types of tumors but are largely silent in normal adult tissues. These genes encode for proteins that are implicated in tumorigenesis and immune evasion, making them of significant interest in cancer research. The GAGE proteins have been identified as potential cancer/testis (CT) antigens, which are typically expressed in male germ cells and various cancers. The study of GAGE12B is particularly relevant due to its possible role in eliciting anti-tumor immune responses, as they may serve as targets for cancer immunotherapy. Research has shown that these proteins can induce T-cell responses in cancer patients, suggesting their potential as candidates for therapeutic applications such as vaccine development. Moreover, understanding the structural and functional properties of GAGE12B can provide insights into its mechanism of action in malignant cells and the immune system's recognition of tumor antigens. The exploration of GAGE12B’s role in cancer biology could lead to innovative strategies for diagnosis and treatment, harnessing the body’s immune response to effectively combat tumors where GAGE12B is aberrantly expressed. As a result, ongoing investigations into GAGE12B and its reconstituted protein forms aim to clarify its involvement in tumor immunity and advance the field of targeted cancer therapies.